Virtus ETF Advisers’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,649
| Closed | -$52.8K | – | 457 |
|
|
2024
Q4 | $52.8K | Sell |
8,649
-2,957
| -25% | -$18.1K | 0.02% | 457 |
|
|
2024
Q3 | $192K | Buy |
11,606
+205
| +2% | +$3.39K | 0.09% | 273 |
|
|
2024
Q2 | $78.3K | Sell |
11,401
-1,931
| -14% | -$13.3K | 0.04% | 412 |
|
|
2024
Q1 | $129K | Sell |
13,332
-911
| -6% | -$8.79K | 0.07% | 343 |
|
|
2023
Q4 | $118K | Buy |
14,243
+4,334
| +44% | +$36K | 0.08% | 323 |
|
|
2023
Q3 | $82.7K | Sell |
9,909
-987
| -9% | -$8.24K | 0.05% | 355 |
|
|
2023
Q2 | $101K | Buy |
10,896
+5,783
| +113% | +$53.4K | 0.06% | 377 |
|
|
2023
Q1 | $70.3K | Sell |
5,113
-1,965
| -28% | -$27K | 0.04% | 403 |
|
|
2022
Q4 | $120K | Sell |
7,078
-241
| -3% | -$4.1K | 0.06% | 414 |
|
|
2022
Q3 | $166K | Buy |
7,319
+52
| +0.7% | +$1.18K | 0.07% | 340 |
|
|
2022
Q2 | $131K | Buy |
7,267
+1,798
| +33% | +$32.4K | 0.05% | 348 |
|
|
2022
Q1 | $146K | Sell |
5,469
-318
| -5% | -$8.49K | 0.07% | 229 |
|
|
2021
Q4 | $170K | Buy |
5,787
+3,574
| +162% | +$105K | 0.06% | 283 |
|
|
2021
Q3 | $146K | Sell |
2,213
-115
| -5% | -$7.59K | 0.06% | 347 |
|
|
2021
Q2 | $194K | Sell |
2,328
-1,106
| -32% | -$92.2K | 0.08% | 362 |
|
|
2021
Q1 | $263K | Buy |
3,434
+60
| +2% | +$4.6K | 0.11% | 276 |
|
|
2020
Q4 | $298K | Sell |
3,374
-1,559
| -32% | -$138K | 0.12% | 215 |
|
|
2020
Q3 | $364K | Sell |
4,933
-659
| -12% | -$48.6K | 0.19% | 182 |
|
|
2020
Q2 | $408K | Buy |
+5,592
| New | +$408K | 0.19% | 191 |
|